Language

This page is only available in English.

The online talk is part of the “Frontiers in Translational Medicine - Scientific and Structural Challenges” on key questions of translation in medicine.

BIH Lecture

"Transparency Matters: A Tale of 1000 and 1 Drug Assessments"

In 2011, Germany implemented a systematic drug assessment process called AMNOG. Transparency is key to AMNOG: All data must be submitted by the manufacturer and the assessment is published in full. This talk will illustrate why this matters and provide a perspective on the forthcoming European benefit assessment (EU-HTA).

About the Speaker

Thomas Kaiser

Director of the Institute for Quality and Efficiency in Health Care (IQWiG).
Physician and System Developer. Co-founder of the German Institute for Evidence-based Medicine (DIeM), Cologne, in 2002. From the founding of the Institute for Quality and Efficiency in Health Care  (IQWiG) in 2004 until 2023: Head of the Drug Assessment Department. Director of IQWiG since 1 April 2023. Recipient of the Bill Silverman Prize of the Cochrane Collaboration (together with 3 other IQWiG staff members) in 2008. Recipient of the David Sackett Prize of the German Network for Evidence-based Medicine  (DNebM) in 2011 (prize awarded to IQWiG‘s Drug Assessment Department).

Info

When
December 4, 2026
12:00 - 1:00 pm

Where
Online via Zoom
>> The login link will be provided shortly before the event.

Registration
Please register here.

Contact

Patricia Ebel

Koordinatorin Veranstaltungen | Redakteurin Online-Kommunikation

Telefon:
+ 49 175 800 5238
E-Mail:
patricia.ebel[at]bih-charite.de